HomeNewsBusinessCovid: HCL Tech working with industry bodies to get its employees and their families vaccinated

Covid: HCL Tech working with industry bodies to get its employees and their families vaccinated

The company, which has 1.59 lakh employees, is in touch with NASSCOM, CII and vaccine producers while awaiting clarity from the government on the vaccination policy

January 25, 2021 / 14:32 IST
Story continues below Advertisement

With the COVID-19 inoculation drive beginning across the country, HCL Tech is currently working with industry bodies to see how quickly its 1.59 lakh employees and their families can get vaccinated, said VV Apparao, Chief Human Resources Officer.

In an interaction with Moneycontrol, Apparao said: “Our intent is that we want our employees and our families to be taken care of. But we are still waiting for guidelines from the government on how this can be taken up.”

Story continues below Advertisement

The vaccination drive began on January 16, 2021 and so far close to 16 lakh have been inoculated. Healthcare professionals will be get vaccine shots in the first phase followed by frontline workers such as armed forces and municipal workers. The third phase will include those who are 50 years or above and those with comorbidities such as hypertension and diabetes.

The company is working with IT industry body NASSCOM and the Confederation of Indian Industry on getting its employees vaccinated. Apparao explained that so far there is not much clarity on how companies can vaccinate their employees. For instance, it is not clear yet if the vaccine will be made available in the retail market, or if the producers can talk to companies and provide the vaccines required.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show